Updates are available Correction dated 2020-10-20
Click to view Correction: https://doi.org/10.1038/s41573-020-0089-1
-
Authors
Moore, Amanda R. https://orcid.org/0000-0003-3864-6387
Rosenberg, Scott C.
McCormick, Frank
Malek, Shiva
- License Information
-
More Information
Article History
Accepted: 24 April 2020
First Online: 11 June 2020
Change Date: 20 October 2020
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41573-020-0089-1
Competing interests
: F.McC. is a consultant for the following companies: Amgen, Pfizer Inc., and Quanta Therapeutics; is a consultant and co-founder with ownership interest including stock options of BridgeBio Pharma, Inc; and is Scientific Director of the NCI Ras Initiative at Frederick National Laboratory for Cancer Research/Leidos Biomedical Research Inc. S.M. is an employee of Genentech/Roche. A.R.M. and S.C.R. are also post-doctoral fellows employed by Genentech/Roche.
